跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,009 条关于
“Legend Capital”
全部
4,009
临床试验
851
药物
87
机构
119
资讯
2,952
9个月前
Allink Biotherapeutics Raises $47M to Advance Two ADC Programs in Global Phase I Trials
上个月
Beyang Therapeutics Closes Oversubscribed $30 Million Series A to Advance AI-Driven Drug Pipeline
去年
Allink Biotherapeutics Secures $42 Million in Series A Funding to Advance Bispecific Antibody and ADC Pipeline
去年
Arnatar Therapeutics Emerges from Stealth with FDA Orphan Drug Designation for ART4 in Alagille Syndrome
去年
Legend Biotech Explores Dual Listing Strategy to Accelerate CAR-T Therapy Expansion
去年
CARVYKTI Demonstrates Significant Survival Benefit in Relapsed/Refractory Multiple Myeloma
去年
Legend Biotech's Carvykti Sales Surge Amidst Net Loss
去年
Carvykti Shows High MRD Negativity Rates in Relapsed/Refractory Multiple Myeloma
上个月
Ex-Legend CEO Ying Huang Takes Helm at K2 Therapeutics as Startup Secures $50M Seed Financing
去年
Lanifibranor Shows Promise in MASH Patients with Type 2 Diabetes: LEGEND Trial Results
第 1 页,共 296 页
上一页
下一页